German producer of thalidomide issues apology, 50 years on | Inquirer News

German producer of thalidomide issues apology, 50 years on

/ 12:27 PM September 01, 2012

A cameraman films a bronze statue by artist Bonifatius Stirnberg that is on display in Stolberg, Germany symbolizing a child born without limbs because of thalidomide Friday Aug, 31, 2012. The drug is a powerful sedative and was sold under the brand name Contergan in Germany. The German manufacturer of a notorious drug that caused thousands of babies to be born with shortened arms and legs, or no limbs at all, issued its first ever apology Friday – 50 years after pulling the drug off the market. Gruenenthal Group’s chief executive said the company wanted to apologize to mothers who took the drug during the 1950s and 1960s and to their children who suffered congenital birth defects as a result. “We ask for forgiveness that for nearly 50 years we didn’t find a way of reaching out to you from human being to human being,” said Harald Stock. “We ask that you regard our long silence as a sign of the shock that your fate caused in us.” Stock spoke in the west German city of Stolberg, where the company is based, during the unveiling of a bronze statue symbolizing a child born without limbs because of thalidomide. (AP Photo/dapd/Jens Schlueter)

LONDON — The German firm that made thalidomide has issued its first apology in over 50 years to the thousands born disabled as a result of the drug’s use, but a victims’ charity called for more tangible action.

Grunenthal’s chief executive Harald Stock said in a speech on Friday that his company was “very sorry” for its silence towards the victims of the drug, which was sold to prefnant women as a cure for morning sickness in the 1950s and early 1960s.

ADVERTISEMENT

An estimated 10,000 children worldwide were born with defects — including missing limbs — after their mothers took thalidomide, which was sold in nearly 50 countries before being pulled from the market in 1961.

FEATURED STORIES

In a translated copy of the German text published on Grunenthal’s website, Harald said he wanted to express his company’s “sincere regrets” and “deep sympathy” to all those affected, “their mothers and their families.”

“We ask that you regard our long silence as a sign of the shock that your fate has caused us,” Harald said in the speech.

“We also apologize for the fact that we have not found the way to you from person to person for almost 50 years.”

Stock delivered the speech at the inauguration of a special memorial to thalidomide victims in Stolberg, western Germany, where the company is based.

He said that the drug “was taken by many women who had no reason to imagine that it could seriously harm their unborn children.”

Stock said his company were taking steps to help the victims of the drug’s use.

ADVERTISEMENT

“We have learned how important it is that we engage in an open dialogue with those affected and to talk and to listen to them,” he said.

“We have begun to mutually develop and implement projects with them, to improve their living situation and assist in hardship situations easily and efficiently.”

But the apology was rejected as insufficient by the charity Thalidomide Agency UK, which represents people affected by the drug in Britain.

Freddie Astbury, the charity’s head consultant, said the company needed to “put their money where their mouth is” rather than simply express regret.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Astbury, who was born in Chester in 1959 without arms or legs after his mother took the drug, said: “If they are serious about admitting they are at fault and regret what happened they need to start helping those of us who were affected financially.”

TAGS: apology, Britain, Children, Germany, Grunenthal, Health, Thalidomide

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.